Miniatura

Fitxers

1342.full.pdf (570.6 KB)

Tipus de document

Article

Data de publicació

2020-05-25

Llicència de publicació

cc by-nc (c) Salazar Mendiguchía, Joel et al., 2020
Si us plau utilitzeu sempre aquest identificador per citar o enllaçar aquest document: https://hdl.handle.net/2445/174053

Mutations in TRIM63 cause an autosomal-recessive form of hypertrophic cardiomyopathy

Títol de la revista

Autors

Director/Tutor

ISSN de la revista

Títol del volum

Recurs relacionat

https://doi.org/10.1136/heartjnl-2020-316913

Resum

Objective: Up to 50% of patients with hypertrophic cardiomyopathy (HCM) show no disease-causing variants in genetic studies. TRIM63 has been suggested as a candidate gene for the development of cardiomyopathies, although evidence for a causative role in HCM is limited. We sought to investigate the relationship between rare variants in TRIM63 and the development of HCM. Methods: TRIM63 was sequenced by next generation sequencing in 4867 index cases with a clinical diagnosis of HCM and in 3628 probands with other cardiomyopathies. Additionally, 3136 index cases with familial cardiovascular diseases other than cardiomyopathy (mainly channelopathies and aortic diseases) were used as controls. Results: Sixteen index cases with rare homozygous or compound heterozygous variants in TRIM63 (15 HCM and one restrictive cardiomyopathy) were included. No homozygous or compound heterozygous were identified in the control population. Familial evaluation showed that only homozygous and compound heterozygous had signs of disease, whereas all heterozygous family members were healthy. The mean age at diagnosis was 35 years (range 15-69). Fifty per cent of patients had concentric left ventricular hypertrophy (LVH) and 45% were asymptomatic at the moment of the first examination. Significant degrees of late gadolinium enhancement were detected in 80% of affected individuals, and 20% of patients had left ventricular (LV) systolic dysfunction. Fifty per cent had non-sustained ventricular tachycardia. Twenty per cent of patients suffered an adverse cerebrovascular event (20%). Conclusion: TRIM63 appears to be an uncommon cause of HCM inherited in an autosomal-recessive manner and associated with concentric LVH and a high rate of LV dysfunction.

Matèries

Miocardiopaties, Mutació (Biologia)

Matèries (anglès)

Myocardiopathies, Mutation (Biology)

Citació

Col·leccions

Articles publicats en revistes (Institut d'lnvestigació Biomèdica de Bellvitge (IDIBELL))

Citació

SALAZAR MENDIGUCHÍA, Joel, OCHOA, Juan pablo, PALOMINO DOZA, Julián, DOMÍNGUEZ, Fernando, DÍEZ LÓPEZ, Carles, AKHTAR, Mohammed, RAMIRO LEÓN, Soraya, CLEMENTE, María m., PÉREZ CEJAS, Antonia, ROBLEDO, María, GÓMEZ DÍAZ, Iria, PEÑA PEÑA, María luisa, CLIMENT, Vicente, SALMERÓN MARTÍNEZ, Francisco, HERNÁNDEZ, Celestino, GARCÍA GRANJA, Pablo elpidio, MOGOLLÓN, M. victoria, CÁRDENAS REYES, Ivonne, CICERCHIA, Marcos, GARCÍA GIUSTINIANI, Diego, LAMOUNIER JR., Arsonval, GIL FOURNIER, Belén, DÍAZ FLORES, Felícitas, SALGUERO, Rafael, SANTOMÉ, Luis, SYRRIS, Petros, OLIVÉ I PLANA, Montserrat, GARCIA PAVIA, Pablo, ORTIZ GENGA, Martín, ELLIOTT, Perry m., MONSERRAT, Lorenzo, Genescopic Research Group. Mutations in TRIM63 cause an autosomal-recessive form of hypertrophic cardiomyopathy. _Heart_. 2020. Vol. 106, núm. 17, pàgs. 1342-1348. [consulta: 21 de gener de 2026]. [Disponible a: https://hdl.handle.net/2445/174053]

Exportar metadades

JSON - METS

Compartir registre